The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
No Access

The effect of low-cost maintenance medication on the rehospitalization of schizophrenic outpatients

Published Online:https://doi.org/10.1176/ajp.134.1.73

In an effort to determine whether expense is a relevant factor when schizophrenic outpatients discontinue maintenance medication, the authors gave low-cost drugs to 44 subjects, while 46 control subjects paid the retail rate. The unexpected result was that the group receiving low-cost drugs had a significantly higher rate of rehospitalization. The authors suggest that monetary investment on the patient's part may be an important factor in successful drug maintenance.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.